Through proteomic and GO analyses, we found that the upregulated proteins p62 and LC3B in the autophagy pathway were enriched after CAPE treatment, indicating that CAPE may exert its drug-sensitizing effects by regulating autophagy in colon cancer cells. The gene discussed is MAP1LC3B; the disease is colonic neoplasm.